People
Adam Robison focuses on a wide range of matters involving healthcare providers and suppliers. A partner in our Healthcare practice, Adam represents healthcare clients in a variety of regulatory and transactional matters.
Adam represents public and private hospital systems, academic medical centers, medical schools, children's hospitals, hospices, laboratories, physicians and suppliers in various regulatory and transactional matters.
Adam counsels clients concerning False Claims Act and Civil Monetary Penalty investigations, fraud and abuse, along with anti-kickback and physician self-referral issues, including physician contracting. He has also worked with clients on Medicare and Medicaid administrative overpayment appeals; Medicare and Medicaid self-disclosures; and compliance with the 60-day overpayment rule; as well as on Medicaid supplemental payment and 1115 Waiver programs.
In addition, Adam advises clients on a variety of transactional matters, including hospital joint operating company agreements, merger and acquisition agreements, and academic affiliation agreements.
J.D., South Texas College of Law, summa cum laude
B.S., Brigham Young University
Texas
June 12, 2024
King & Spalding Earns Top-Tier Rankings in Legal 500 United States 2024 Guide
June 6, 2024
King & Spalding Earns 198 Lawyer Rankings, 90 Practice Group Rankings in Chambers USA Guide
June 8, 2023
King & Spalding Earns Top-Tier Rankings in Legal 500 United States 2023 Guide
Litigation/Administrative Appeals
Successfully represented a large healthcare company in obtaining an $18 million arbitration award against the sellers of a hospice pursuant to claims for indemnification and fraud related to a self-disclosure audit that Adam also facilitated.
Successfully represented a drug testing laboratory in reducing a $31 million Medicare overpayment resulting in more than a $29 million overpayment reduction.
Represented an oncologist before the Administrative Law Judge in a Medicare overpayment case resulting in the full reversal of the alleged multimillion-dollar overpayment.
See more
October 14, 2024
United States District Court in Florida Holds False Claims Act Qui Tam Provision Unconstitutional
October 10, 2024
United States District Court in Florida Holds False Claims Act Qui Tam Provision Unconstitutional
November 9, 2023
General Counsel’s Decision Tree for Internal Investigations for the Healthcare Industry
June 12, 2024
King & Spalding Earns Top-Tier Rankings in Legal 500 United States 2024 Guide
June 6, 2024
King & Spalding Earns 198 Lawyer Rankings, 90 Practice Group Rankings in Chambers USA Guide
June 8, 2023
King & Spalding Earns Top-Tier Rankings in Legal 500 United States 2023 Guide
Litigation/Administrative Appeals
Successfully represented a large healthcare company in obtaining an $18 million arbitration award against the sellers of a hospice pursuant to claims for indemnification and fraud related to a self-disclosure audit that Adam also facilitated.
Successfully represented a drug testing laboratory in reducing a $31 million Medicare overpayment resulting in more than a $29 million overpayment reduction.
Represented an oncologist before the Administrative Law Judge in a Medicare overpayment case resulting in the full reversal of the alleged multimillion-dollar overpayment.
See more
October 14, 2024
United States District Court in Florida Holds False Claims Act Qui Tam Provision Unconstitutional
October 10, 2024
United States District Court in Florida Holds False Claims Act Qui Tam Provision Unconstitutional
November 9, 2023
General Counsel’s Decision Tree for Internal Investigations for the Healthcare Industry
June 12, 2024
King & Spalding Earns Top-Tier Rankings in Legal 500 United States 2024 Guide
June 6, 2024
King & Spalding Earns 198 Lawyer Rankings, 90 Practice Group Rankings in Chambers USA Guide
June 8, 2023
King & Spalding Earns Top-Tier Rankings in Legal 500 United States 2023 Guide
J.D., South Texas College of Law, summa cum laude
B.S., Brigham Young University
Texas